Stock Research for IDRA

Current Price


Latest Update: 2018-03-16 16:00:00

$ 1.9500
$ 1.9400
$ 1.9500

Featured Broker: TradeStation

Get the due diligence for another stock.


IDRA Stock Chart & Research Data

The IDRA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the IDRA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


IDRA Due diligence Resources & Stock Charts

The IDRA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View IDRA Detailed Price Forecast - CNN Money CNN View IDRA Detailed Summary - Google Finance
Yahoo View IDRA Detailed Summary - Yahoo! Finance Zacks View IDRA Stock Research & Analysis -

Stock Analysis

TradeIdeas View IDRA Trends & Analysis - Trade-Ideas Barrons View IDRA Major Holders - Barrons
NASDAQ View IDRA Call Transcripts - NASDAQ Seeking View IDRA Breaking News & Analysis - Seeking Alpha
Spotlight View IDRA Annual Report - OTC Report View IDRA OTC Short Report -
TradeKing View IDRA Fundamentals - TradeKing Charts View IDRA SEC Filings - Bar Chart
WSJ View Historical Prices for IDRA - The WSJ Morningstar View Performance/Total Return for IDRA - Morningstar
MarketWatch View the Analyst Estimates for IDRA - MarketWatch CNBC View the Earnings History for IDRA - CNBC
StockMarketWatch View the IDRA Earnings - StockMarketWatch MacroAxis View IDRA Buy or Sell Recommendations - MacroAxis
Bullish View the IDRA Bullish Patterns - American Bulls Short Pains View IDRA Short Pain Metrics -

Social Media Mentions

StockTwits View IDRA Stock Mentions - StockTwits PennyStocks View IDRA Stock Mentions - PennyStockTweets
Twitter View IDRA Stock Mentions - Twitter Invest Hub View IDRA Investment Forum News - Investor Hub
Yahoo View IDRA Stock Mentions - Yahoo! Message Board Seeking Alpha View IDRA Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for IDRA - Insider Cow View Insider Transactions for IDRA - Insider Cow
CNBC View IDRA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for IDRA - OTC Markets
Yahoo View Insider Transactions for IDRA - Yahoo! Finance NASDAQ View Institutional Holdings for IDRA - NASDAQ

Stock Charts

FinViz View IDRA Stock Insight & Charts - StockCharts View IDRA Investment Charts -
BarChart View IDRA Stock Overview & Charts - BarChart Trading View View IDRA User Generated Charts - Trading View

Latest Financial News for IDRA

Catalyst Pharmaceuticals Inc (CPRX) and Achillion Pharmaceuticals, Inc. (ACHN) Among Five Cheap Healthcare Stocks To Buy Now
Posted on Wednesday March 14, 2018

There are plenty of opportunities to invest in healthcare stocks, as there are thousands of companies, ranging from big and well-established pharmaceuticals that also pay substantial dividends, to small, emerging companies without any products on the market or revenue, but backed by their research into novelty therapies for various illnesses. When looking for healthcare stocks […]

Idera reports 4Q loss
Posted on Wednesday March 07, 2018

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 8 cents. The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment ...

Idera Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update
Posted on Wednesday March 07, 2018

EXTON, Pa. and CAMBRIDGE, Mass., March 07, 2018-- Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel nucleic acid-based ...

Idera Pharmaceuticals Announces Launch of Global Phase 3 Trial Evaluating IMO-2125 in Combination with Ipilimumab for the Treatment of Anti-PD-1 Refractory Melanoma (ILLUMINATE 301)
Posted on Thursday March 01, 2018

EXTON, Pa. and CAMBRIDGE, Mass., March 01, 2018-- Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with rare cancers ...

Warning: DOMDocument::load( failed to open stream: HTTP request failed! HTTP/1.0 404 Not Found in /home/allsites/ on line 494

Warning: DOMDocument::load(): I/O warning : failed to load external entity "" in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.